Skip to main content

and
  1. Article

    Open Access

    Decreased functional activity of multidrug resistance protein in primary colorectal cancer

    The ATP-Binding Cassette (ABC)-transporter MultiDrug Resistance Protein 1 (MDR1) and Multidrug Resistance Related Protein 1 (MRP1) are expressed on the surface of enterocytes, which has led to the belief that ...

    Tamás Micsik, András Lőrincz, Tamás Mersich, Zsolt Baranyai in Diagnostic Pathology (2015)

  2. No Access

    Protocol

    Screening for MAPK Modulators Using an In-Cell Western Assay

    Several essential cellular functions are critically influenced by the Ras-Raf-MEK-ERK cascade, and pathological problems have been implicated with loss as well as gain of its activity. Therefore, there is a gr...

    Simon Schnaiter, Beatrix Fürst, Johannes Neu, Frigyes Wáczek, László Őrfi in Ras Signaling (2014)

  3. No Access

    Article

    Integrating molecular diagnostics into anticancer drug discovery

    Efforts to repeat the success of pioneering molecularly targeted cancer drugs, such as trastuzumab, for particular patient populations have been hampered by factors such as a lack of correlation between the mo...

    István Peták, Richárd Schwab, László Őrfi, László Kopper in Nature Reviews Drug Discovery (2010)

  4. No Access

    Article

    Proteomics strategy for quantitative protein interaction profiling in cell extracts

    Quantitative information is necessary to determine which protein interactions are the most relevant in a cellular context. A defined set of affinity purification experiments combined with quantitative mass spe...

    Kirti Sharma, Christoph Weber, Michaela Bairlein, Zoltán Greff in Nature Methods (2009)

  5. Article

    Open Access

    The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients

    Genomics and proteomics will improve outcome prediction in cancer and have great potential to help in the discovery of unknown mechanisms of metastasis, ripe for therapeutic exploitation. Current methods of pr...

    Muireann T. Kelleher, Gilbert Fruhwirth, Gargi Patel, Enyinnaya Ofo in Targeted Oncology (2009)

  6. No Access

    Article

    Binding specificity of the l-arginine transport systems in mouse macrophages and human cells overexpressing the cationic amino acid transporter hCAT-1

    The uptake of l-arginine into mouse peritoneal macrophages can be inhibited by numerous amino acids and derivatives. Kinetic studies showed an almost entirely competitive inhibition for both cationic and neutral ...

    Dániel Erős, László Őrfi, Ildikó Csuka, György Kéri, András Hrabák in Amino Acids (2009)

  7. Article

    Open Access

    TT-232: An Anti-tumour and Anti-inflammatory Peptide Therapeutic in Clinical Development

    TT-232 is a structural derivative of the peptide hormone somatostatin with selective anti-proliferative and anti-inflammatory properties. It has a strong anti-tumour activity both in vitro and in vivo on a wide r...

    György Kéri, Richard Schwab in International Journal of Peptide Research … (2005)

  8. No Access

    Article

    Validation subset selections for extrapolation oriented QSPAR models

    One of the most important features of QSPAR models is their predictive ability. The predictive ability of QSPAR models should be checked by external validation. In this work we examined three different types o...

    Csaba Szántai-Kis, István Kövesdi, György Kéri, László Örfi in Molecular Diversity (2003)

  9. No Access

    Article

    Pharmacological characterisation of the somatostatin analogue TT-232: effects on neurogenic and non-neurogenic inflammation and neuropathic hyperalgesia

    The putative anti-inflammatory and anti-nociceptive activity of the heptapeptide somatostatin analogue TT-232 (D-Phe-Cys-Tyr-D-Thr-Lys-Cys-Thr-NH2) was investigated in the rat and mouse, as well as its effect on ...

    Erika Pintér, Zsuzsanna Helyes in Naunyn-Schmiedeberg's Archives of Pharmaco… (2002)

  10. No Access

    Chapter

    Peptidomimetic tyrosine kinase inhibitors induce non apoptotic, Clarke-III type programmed cell death

    György Kéri, László Ôrfi, Gergely Szántó in Peptides Frontiers of Peptide Science (2002)

  11. No Access

    Chapter

    Further Studies of the Signaling Mechanisms of the Antitumor Somatostatin Analogue TT-232

    The somatostatin structural analogue TT-232 is a heptapeptide of a cyclopenta-ring structure: D-Phe-Cys-Tyr-D-Thr-Lys-Cys-Thr-NH2 that was shown to have strong antiproliferative and apoptotic effects on tumor cel...

    Attila Steták, Tibor Vántus, Gyöngyi Bökönyi in Peptides: The Wave of the Future (2001)

  12. No Access

    Chapter

    New Antiproliferative Agents from a Peptidomimetic Library

    It is known that chiral ATP analogue quinazolines show selective Epidermal Growth Factor Receptor Tyrosine Kinase (EGFR TK) inhibitory activity depending on the chirality of the molecule [1]. We have developed...

    László Őrfi, Györgyi Bökönyi, Anikó Horváth in Peptides: The Wave of the Future (2001)

  13. No Access

    Chapter

    HPLC Analysis, Modeling, and Biological Studies of Antiproliferative Heterocyclic Carboxamides

    Reversed phase HPLC and MEKC [1] provide excellent possibilities to measure the hydrophobic properties of compounds, characterizing them directly from the chromatographic retention time. The aim in this respec...

    János Seprõdi, Ferenc Hollósy, Dániel Erõs, László Õrfi in Peptides: The Wave of the Future (2001)

  14. No Access

    Article

    New antitumor leads from a peptidomimetic library

    A parallel combinatorial library of over 1600 compounds has been designed and synthesized for the development of new potential peptidomimetic protein tyrosine kinase (PTK) inhibitor leads. These peptidomimetic...

    László Õrfi, Frigyes Wáczek, István Kövesdi, György Mészáros in Letters in Peptide Science (1999)

  15. No Access

    Article

    New antitumor leads from a peptidomimetic library

    A parallel combinatorial library of over 1600 compounds has been designed and synthesized for the development of new potential peptidomimetic protein tyrosine kinase (PTK) inhibitor leads. These peptidomimetic...

    László Õrfi, Frigyes Wáczek, István Kövesdi, György Mészáros in Letters in Peptide Science (1999)

  16. No Access

    Chapter

    Biodegradation of Luteinizing Hormone-Releasing Hormone

    The concept that the proteolytic degradation of peptide hormones could be one of the key mechanisms regulating the homeostasis of the hormone, as proposed by Knights et al. (1973), is widely accepted. However, cu...

    Károly Nikolics, György Kéri, Balázs Szöke in Hormonally Active Brain Peptides (1982)

  17. No Access

    Chapter

    Tritium Labeling of Brain Peptides

    During the past decade, radiolabeling of biologically active peptides has become a widely applied and essential technique for a variety of biochemical and physiological investigations.

    István Teplán, Imre Mező, Károly Nikolics in Hormonally Active Brain Peptides (1982)